ScholarLens Back to search
2005•Behavioural PharmacologyRequires access

S37 INVOLVEMENT OF THE ENDOCANNABINOID SYSTEM IN THE REGULATION OF FEEDING BEHAVIOUR AND BODY WEIGHT: PHARMACOLOGICAL EFFECTS OF RIMONABANT, A CB1 CANNABINOID RECEPTOR ANTAGONIST

Michele Arnone, Christine Ravinet‐Trillou, B. Scatton

Open publisher page 0 citations

Abstract

Central Nervous System, Sanofi-Aventis, Toulouse, France Abstracts of the 11th Biennial EBPS Meeting

About this research paper

What this paper is about

Central Nervous System, Sanofi-Aventis, Toulouse, France Abstracts of the 11th Biennial EBPS Meeting

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Central Nervous System, Sanofi-Aventis, Toulouse, France Abstracts of the 11th Biennial EBPS Meeting

Key concepts: Rimonabant, Cannabinoid receptor, Endocannabinoid system, Cannabinoid receptor antagonist, Cannabinoid, Antagonist, Pharmacology, Chemistry

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
S37 INVOLVEMENT OF THE ENDOCANNABINOID SYSTEM IN THE REGULATION OF FEEDING BEHAVIOUR AND BODY WEIGHT: PHARMACOLOGICAL EFFECTS OF RIMONABANT, A CB1 CANNABINOID RECEPTOR ANTAGONIST — Research Paper | ScholarLens